Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives

N Vallianou, GS Christodoulatos, I Karampela… - Biomolecules, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. NAFLD begins as a relatively benign hepatic steatosis which can evolve to non …

Health functions and related molecular mechanisms of tea components: An update review

GY Tang, X Meng, RY Gan, CN Zhao, Q Liu… - International journal of …, 2019 - mdpi.com
Tea is widely consumed all over the world. Generally, tea is divided into six categories:
White, green, yellow, oolong, black, and dark teas, based on the fermentation degree. Tea …

The role of the gut microbiota in NAFLD

C Leung, L Rivera, JB Furness… - … reviews Gastroenterology & …, 2016 - nature.com
NAFLD is now the most common cause of liver disease in Western countries. This Review
explores the links between NAFLD, the metabolic syndrome, dysbiosis, poor diet and gut …

[HTML][HTML] The safety of green tea and green tea extract consumption in adults–results of a systematic review

J Hu, D Webster, J Cao, A Shao - Regulatory toxicology and pharmacology, 2018 - Elsevier
A systematic review of published toxicology and human intervention studies was performed
to characterize potential hazards associated with consumption of green tea and its …

Treatment of non‐alcoholic fatty liver disease with curcumin: A randomized placebo‐controlled trial

S Rahmani, S Asgary, G Askari… - Phytotherapy …, 2016 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) is a global health problem. Although many
aspects of NAFLD pathogenesis have been understood, there is a paucity of effective …

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

M Bagherniya, V Nobili, CN Blesso… - Pharmacological research, 2018 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver diseases, and is closely
related to metabolic syndrome and its related conditions, diabetes mellitus and dyslipidemia …

Scientific opinion on the safety of green tea catechins

EFSA Panel on Food Additives and Nutrient … - EFSA …, 2018 - Wiley Online Library
Abstract The EFSA ANS Panel was asked to provide a scientific opinion on the safety of
green tea catechins from dietary sources including preparations such as food supplements …

[HTML][HTML] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023 - Elsevier
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

Plant‐based foods and their bioactive compounds on fatty liver disease: Effects, mechanisms, and clinical application

HY Li, RY Gan, A Shang, QQ Mao… - Oxidative medicine …, 2021 - Wiley Online Library
Fatty liver disease (FLD), including nonalcoholic fatty liver disease (NAFLD) and alcoholic
fatty liver disease (AFLD), is a serious chronic metabolic disease that affects a wide range of …

Role of natural phenolics in hepatoprotection: a mechanistic review and analysis of regulatory network of associated genes

P Saha, AD Talukdar, R Nath, SD Sarker… - Frontiers in …, 2019 - frontiersin.org
The liver is not only involved in metabolism and detoxification, but also participate in innate
immune function and thus exposed to frequent target Thus, they are the frequent target of …